Critical reappraisal of remdesivir investigational trials in COVID-19

被引：2
|
作者：
Brouqui, P. [1 ]
Giraud-Gatineau, A. [1 ]
Raoult, D. [1 ]
机构：
[1] Aix Marseille Univ, IRD, MEPHI, IHU Mediterranee Infect, Marseille, France
来源：
NEW MICROBES AND NEW INFECTIONS | 2020年 / 38卷
关键词：
Clinical trials; COVID-19; remdesivir; treatment; CORONAVIRUS;
D O I：
10.1016/j.nmni.2020.100745
中图分类号：
R51 [传染病];
学科分类号：
100401 ;
摘要：
During disease outbreaks, the pharmaceutical industry generally puts a lot of effort into promoting clinical trials studying their new drugs. We review evidence of the ten most recent reports on remdesivir. We conclude that it is far too premature to identify remdesivir as a curative or life-saving intervention during the COVID-19 pandemic. (C) 2020 The Author(s). Published by Elsevier Ltd.
引用
收藏
页数：5
相关论文
共 50 条
  • [1] Remdesivir in treating hospitalized patients with COVID-19: A renewed review of clinical trials
    Wu, Zhenchao
    Han, Zhifei
    Liu, Beibei
    Shen, Ning
    FRONTIERS IN PHARMACOLOGY, 2022, 13
  • [2] The use of remdesivir outside of clinical trials during the COVID-19 pandemic
    Vesa Halimi
    Armond Daci
    Nevenka Ridova
    Irina Panovska-Stavridis
    Milena Stevanovic
    Venko Filipce
    Aleksandar Dimovski
    Aleksandra Grozdanova
    Journal of Pharmaceutical Policy and Practice, 13
  • [3] The use of remdesivir outside of clinical trials during the COVID-19 pandemic
    Halimi, Vesa
    Daci, Armond
    Ridova, Nevenka
    Panovska-Stavridis, Irina
    Stevanovic, Milena
    Filipce, Venko
    Dimovski, Aleksandar
    Grozdanova, Aleksandra
    JOURNAL OF PHARMACEUTICAL POLICY AND PRACTICE, 2020, 13 (01)
  • [4] Remdesivir: Critical Clinical Appraisal for COVID 19 Treatment
    Chatterjee, Saptarshi
    DRUG RESEARCH, 2021, 71 (03) : 138 - 148
  • [5] Use of Remdesivir in Myasthenia gravis and COVID-19
    Peters, Bradley J.
    Rabinstein, Alejandro A.
    DuBrock, Hilary M.
    PHARMACOTHERAPY, 2021, 41 (06): : 546 - 550
  • [6] Remdesivir, a remedy or a ripple in severe COVID-19?
    Doggrell, Sheila A.
    EXPERT OPINION ON INVESTIGATIONAL DRUGS, 2020, 29 (11) : 1195 - 1198
  • [7] Clinical trials: Management of investigational products during the COVID-19 pandemic
    Flet, Laurent
    Tching-Sin, Martine
    Chanat, Adeline
    Gendre, Pauline
    Tibi, Annick
    AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY, 2020, 77 (16) : 1277 - 1278
  • [8] Available Evidence and Ongoing Clinical Trials of Remdesivir: Could It Be a Promising Therapeutic Option for COVID-19?
    Sisay, Mekonnen
    FRONTIERS IN PHARMACOLOGY, 2020, 11
  • [9] Remdesivir in covid-19
    Ferner, Robin E.
    Aronson, Jeffrey K.
    BMJ-BRITISH MEDICAL JOURNAL, 2020, 369
  • [10] Remdesivir and its antiviral activity against COVID-19: A systematic review
    Frediansyah, Andri
    Nainu, Firzan
    Dhama, Kuldeep
    Mudatsir, Mudatsir
    Harapan, Harapan
    CLINICAL EPIDEMIOLOGY AND GLOBAL HEALTH, 2021, 9 : 123 - 127
12345